Durham-based startup targeting diabetes raises $4.6M, looks for another $10.4M
Aerami Therapeutics, formerly known as Dance Biopharm Holdings Inc., has raised $4.6 million in equity, according to a securities filing.
Read More
Type 2 diabetes
